Cart
sales@molnova.com
Isorhamnetin-3-O-neohespeidoside
CAS No. 55033-90-4
Isorhamnetin-3-O-neohespeidoside( —— )
Catalog No. M14990 CAS No. 55033-90-4
Isorhamnetin-3-O-neohespeidoside is a flavonol glycoside extract used as an anti-oxidant.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 67 | In Stock |
|
| 5MG | 44 | In Stock |
|
| 10MG | 60 | In Stock |
|
| 25MG | 93 | In Stock |
|
| 50MG | 137 | In Stock |
|
| 100MG | 200 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameIsorhamnetin-3-O-neohespeidoside
-
NoteResearch use only, not for human use.
-
Brief DescriptionIsorhamnetin-3-O-neohespeidoside is a flavonol glycoside extract used as an anti-oxidant.
-
DescriptionIsorhamnetin-3-O-neohespeidoside is a flavonol glycoside extract used as an anti-oxidant.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorOthers
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number55033-90-4
-
Formula Weight624.54
-
Molecular FormulaC28H32O16
-
Purity>98% (HPLC)
-
SolubilitySoluble in Pyridine, Methanol, Ethanol
-
SMILESC[C@H]1[C@@H]([C@H]([C@H]([C@@H](O1)O[C@@H]2[C@H]([C@@H]([C@H](O[C@H]2OC3=C(OC4=CC(=CC(=C4C3=O)O)O)C5=CC(=C(C=C5)O)OC)CO)O)O)O)O)O
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Li CY,et al. Measurement of hydroxysafflor yellow A in human urine by liquid chromatography-tandem mass spectrometry.J Chromatogr B Analyt Technol Biomed Life Sci.
molnova catalog
related products
-
Rhodamine 800
Rhodamine 800 is a near-infrared fluorescent dye. The absorption maximum at 683 nm in acetone shifts to 696 nm in DMSO without a significant change of the overall spectral profile.
-
3,3-Dihydroxy-4,5,7-...
The barks of Cinnamomum cassia.
-
FEN1 Inhibitor C2
FEN1-IN-4 is an inhibitor of human flap endonuclease-1 (hFEN1)FEN1 Inhibitor C2 inhibition selectively impairs proliferation of colon cancer cells deficient in Cdc4 and Mre11a, both frequently mutated in colorectal cancers.?
